E.g. Oncocross is an Artificial Intelligence-based pharmaceutical company specializing in drug discovery/cancer drug development.

E.g. Oncocross is an Artificial Intelligence based biotech specializing in drug development. Oncocross' service is based on the two AI platform described below: ONCO AI - is an AI platform to screen optimal indications for drug compound in preclinical or clinical stages and to find the most suitable combination drugs to develop Incrementally Modified Drug (IMD) or orphan drugs, using proprietary human transcriptomic data (RNA expression), disease data, and drug data. Using ONCO AI, we can accelerate drug development process in a shorter time at a lower cost. ONCOfind AI - is an AI platform to screen and identify the most suitable biomarker for anti-cancer drug compound candidate using proprietary standardized human transcriptomic data of multiple races and various phenotype information of cancer. This platform can also identity the original anatomic site of primary cancer tumor for Carcinoma of Unknown Primary (CUP).

This will be the first section of your startup profile that will be read by investors. Please highlights your startup's traction, achievements, growth, patents, MoUs, awards, number of clients, clients' names etc. Please present this information as bullet points.

please use max 1mb of size and use jpg, jpeg or png

please use max 1mb of size and use jpg, jpeg or png

please use max 1mb of size and use jpg, jpeg or png